[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80307]], camposKey:2072-6643 2023-09-01 ß-Alanine Supplementation in Combat Sports: Evaluation of Sports Performance, Perception, and Anthropometric Parameters and Biochemical Markers¿A Systematic Review of Clinical Trials00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80309]], camposKey:2072-6643 2023-06-01 Influence of N-Acetylcysteine Supplementation on Physical Performance and Laboratory Biomarkers in Adult Males: A Systematic Review of Controlled Trials00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80311]], camposKey:1424-8247 2023-04-01 Trends in the Use of Driving-Impairing Medicines According to the DRUID Category: A Population-Based Registry Study with Reference to Driving in a Region of Spain between 2015 and 201900, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75026]], camposKey:1010-660X 2023-02-01 Impact of Innovative Treatment Using Biological Drugs for the Modulation of Diffuse Cutaneous Systemic Sclerosis: A Systematic Review00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75819]], camposKey:2574-3805 2023-01-13 Economic Burden of the 2020 COVID-19 Hospitalizations in Spain00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80753]], camposKey:2296-2565 2023-01-01 Increase in driving after cocaine use in Spain: a cross-sectional dataset analysis for 202100, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80313]], camposKey:1663-9812 2023-01-01 Medication economic burden of antidepressant non-adherence in Spain00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80752]], camposKey:2296-2565 2023-01-01 Prevalence and cost of hospitalized patients with asymptomatic COVID-19 in 2020 in Spain00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65058]], camposKey:1364-8535 2022-12-01 Hyperoxemia in postsurgical sepsis/septic shock patients is associated with reduced mortality00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75668]], camposKey:1999-4923 2022-12-01 Non-Adherence to Antidepressant Treatment and Related Factors in a Region of Spain: A Population-Based Registry Study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68805]], camposKey:1010-660X 2022-06-01 Hospitalized COVID-19 Patients with Severe Acute Respiratory Syndrome: A Population-Based Registry Analysis to Assess Clinical Findings, Pharmacological Treatment and Survival00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76198]], camposKey:1661-7827 2022-01-01 Adequacy of an Altitude Fitness Program (Living and Training) plus Intermittent Exposure to Hypoxia for Improving Hematological Biomarkers and Sports Performance of Elite Athletes: A Single-Blind Randomized Clinical Trial00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73290]], camposKey:1135-5727 2022-01-01 Tendencia del consumo de fármacos en el trastorno por déficit de atención e hiperactividad en niños y adolescentes (2010-2019)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=82891]], camposKey:2308-3425 2021-12-01 A population-based registry analysis on hospitalized covid-19 patients with previous cardiovascular disease: Clinical profile, treatment, and predictors of death00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=82892]], camposKey:2072-6643 2021-11-01 Impact of optimal timing of intake of multi-ingredient performance supplements on sports performance, muscular damage, and hormonal behavior across a ten-week training camp in elite cyclists: A randomized clinical trial00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=82893]], camposKey:2296-858X 2021-06-15 Clinical Profile, Pharmacological Treatment, and Predictors of Death Among Hospitalized COVID-19 Patients With Acute Kidney Injury: A Population-Based Registry Analysis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58802]], camposKey:1661-7827 2021-05-02 Positivity to cocaine and/or benzoylecgonine in confirmation analyses for on-road tests in spain00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61689]], camposKey:2296-858X 2021-01-01 Binding Potassium to Improve Treatment With Renin-Angiotensin-Aldosterone System Inhibitors: Results From Multiple One-Stage Pairwise and Network Meta-Analyses of Clinical Trials00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58803]], camposKey:0767-3981 2021-01-01 Trends in the use of antihistamines with reference to drivers between 2015 and 2019: A population-based registry analysis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58793]], camposKey:0214-3429 2020-12-01 Trend in the use of topical ocular anti-infectives in a region of Spain between 2015 and 2019: a population-based registry study453458, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=82894]], camposKey:1424-8247 2020-08-01 Population-based registry analysis of antidiabetics dispensations: Trend use in Spain between 2015 and 2018 with reference to driving112, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58804]], camposKey:1661-7827 2020-01-01 Clinical profile, treatment and predictors during the first covid-19 wave: A population-based registry analysis from castile and leon hospitals115, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55560]], camposKey:1424-8247 2020-01-01 Trends in antidepressants use in Spain between 2015 and 2018: Analyses from a population-based registry study with reference to driving00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49045]], camposKey:0268-1315 2019-01-01 Antipsychotics in the general population and the driver population: comparisons from a population-based registry study184188, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52138]], camposKey:2077-0383 2019-01-01 The Trends in Opioid Use in Castile and Leon, Spain: A Population-Based Registry Analysis of Dispensations in 2015 to 201800, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58877]], camposKey:2530-0180 2018-12-01 Clinical response to growth hormone in children with intrauterine growth retardation without catch-up growth in Castilla y Leon (Spain)584591, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=82889]], camposKey:2530-0164 2018-01-01 Respuesta clínica al tratamiento con hormona de crecimiento en niños con retraso de crecimiento intrauterino sin recuperación posnatal de talla en Castilla y León584591, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37971]], camposKey:1663-9812 2018-01-01 The problem of benzodiazepine use and its extent in the driver population: A population-based registry study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49047]], camposKey:2044-6055 2017-01-01 Use of driving-impairing medicines by a Spanish population: a population-based registry study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58878]], camposKey:0025-7753 2015-12-21 Smoking impact on mortality in Spain in 2012520525, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=82885]], camposKey:0025-7753 2015-01-01 Impacto del consumo de tabaco sobre la mortalidad en España en el año 2012520525, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=82887]], camposKey:1696-8077 2010-01-01 La aterosclerosis como desencadenante de la patología cardiovascular00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=82886]], camposKey:1139-7357 2009-01-01 Recomendaciones sobre el modo de actuar ante un olvido de dosis de medicación prescrita245252, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=82888]], camposKey:1696-8077 2006-01-01 Efectos de los antioxidantes en la prevención de patologías cardiovasculares00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=78271]], camposKey:1696-8077 2004-01-01 Efectos de los antioxidantes en la prevención de patologías cardiovasculares00][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=34000]},camposKey: 280 Dibujos de histología en ciencias de la salud: aprendizaje colaborativo modelo Cajal 978-84-09-48185-9Libro de actas del Congreso Universitario Internacional sobre Comunicación, Innovación, Investigación y Docencia: CUICIID 2023 1 2023-01-01 Fórum Internacional de Comunicación y Relaciones públicas (Fórum XXI), CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=33999]},camposKey: 287 La elaboración de flashcards como herramienta de innovación docente para la enseñanza de la farmacología. 978-84-09-48185-9Libro de actas del Congreso Universitario Internacional sobre Comunicación, Innovación, Investigación y Docencia: CUICIID 2023 1 2023-01-01 Fórum Internacional de Comunicación y Relaciones públicas (Fórum XXI), CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=31126]},camposKey: 601 606 Autoevaluación y prácticas de farmacología en el Grado de Medicina: Tensión arterial 978-84-124511-6-0Conference proceedings. CIVINEDU 2022: 6th International Virtual Conference on Educational Research and Innovation 1 2022-01-01 REDINE (Red de Investigación e Innovación Educativa) , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=26782]},camposKey: 449 453 Utilización de "Píldoras de Conocimiento" para la innovación docente en farmacología 978-84-124511-1-5Conference proceedings. CIVINEDU 2021: 5th International Virtual Conference onEducational Research and Innovation 1 2021-01-01 Adaya Press , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=26783]},camposKey: 430 435 Utilización de programas de simulación informática en la enseñanza práctica de farmacología 978-84-124511-1-5Conference proceedings. CIVINEDU 2021: 5th International Virtual Conference onEducational Research and Innovation 1 2021-01-01 Adaya Press ][com.sigma.fs3.argos.domain.gpc.ColabRevistes[id=com.sigma.fs3.argos.domain.gpc.GpcColabRevistesPK[ifcactivitat=COL, ifccomptador=1587]], com.sigma.fs3.argos.domain.gpc.ColabRevistes[id=com.sigma.fs3.argos.domain.gpc.GpcColabRevistesPK[ifcactivitat=COL, ifccomptador=1586]]][][][][][][][][com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=753]]][com.sigma.fs3.argos.domain.gpc.Premis[id=com.sigma.fs3.argos.domain.gpc.GpcPremisPK[ifcactivitat=PRE, ifccomptador=753]]][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30804]]][][][][][][com.sigma.fs3.argos.domain.gpc.GpcComissioAssessor[id=com.sigma.fs3.argos.domain.gpc.GpcComissioAssessorPK[ifcactivitat=COM, ifccomptador=1099]], com.sigma.fs3.argos.domain.gpc.GpcComissioAssessor[id=com.sigma.fs3.argos.domain.gpc.GpcComissioAssessorPK[ifcactivitat=COM, ifccomptador=1098]], com.sigma.fs3.argos.domain.gpc.GpcComissioAssessor[id=com.sigma.fs3.argos.domain.gpc.GpcComissioAssessorPK[ifcactivitat=COM, ifccomptador=1101]]][GpcPartTribunals[ gpcPartTribunalsPK=GpcPartTribunalsPK[ ifcactivitat=PTR, ifccomptador=433 ] ]][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@162ef724, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@6a34e5f4, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@4ebf9100, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@faab472, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@6e5ce574, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@238aa60e, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@118f04ee, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@4b5c2b89, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@422200d3, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@34ee744f, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@5d2fbe48, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7705c607, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@25f364ac][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64da9d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64ce19, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64d35d][][][][][][][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c12b9], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c12ba], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c1959], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c1956], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c1957], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c1953], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c1960]][][][][][][com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@17a81, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@175b6, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@17991, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@16f8c, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@1704a, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@17053, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@16d8a, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@16d9f, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@16de8, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@15d87][]